MedPath

Amiodarone Hydrochloride

These highlights do not include all the information needed to use Amiodarone Hydrochloride Injection, USP safely and effectively. See full prescribing information for Amiodarone Hydrochloride Injection, USP. AMIODARONE Hydrochloride Injection, USP for intravenous use Initial U.S. Approval: 1995

Approved
Approval ID

e9151c1b-b70c-477b-868a-fffdc5c51830

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 7, 2025

Manufacturers
FDA

REMEDYREPACK INC.

DUNS: 829572556

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Amiodarone Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70518-1231
Application NumberANDA077234
Product Classification
M
Marketing Category
C73584
G
Generic Name
Amiodarone Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 7, 2025
FDA Product Classification

INGREDIENTS (4)

POLYSORBATE 80Inactive
Quantity: 100 mg in 1 mL
Code: 6OZP39ZG8H
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 20.2 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
AMIODARONE HYDROCHLORIDEActive
Quantity: 50 mg in 1 mL
Code: 976728SY6Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.